Kashyap Tele-Medicines Ltd (BSE: 531960) is a Navi Mumbai, Maharashtra-based company in the Information Technology (IT) Consulting industry. With a market capitalisation of ₹31 Cr, it ranks #4,254 by market cap among the 6,137 Indian listed companies on FinBizNet, and #88 of 116 in Information Technology (IT) Consulting. At ₹6.41 (as of 25 Oct 2026), the share price is 48.7% below its 52-week high of ₹12.50 and 52.6% above its 52-week low of ₹4.20. The share price is down 12.5% over one year and up 10.1% over three months.
| Current Price | ₹6.41 |
|---|---|
| Market Cap | ₹31 Cr |
| BSE Code | 531960 |
| Sector | Information Technology > Software and Services > IT Services |
| Sub-Industry | IT Consulting and Other Services > Information Technology (IT) Consulting |
| P/E Ratio | -66.1 |
| Return on Equity | -112.20% |
| Return on Assets | -45.75% |
| 52-Week Range | ₹4.20 – ₹12.50 |
| 1-Year Price Change | -12.5% |
| 3-Month Price Change | +10.1% |
| Beta (1Y) | -0.13 |
| Headquarters | Navi Mumbai, Maharashtra |
| Website | kashyaptele-medicines.com |
| Revenue | ₹0 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 70.0% |
| EPS (Basic) | ₹0.03 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Kashyap Tele-Medicines Limited provides information technology services in India. The company offers software development, onshore and offshore, distribution, implementation, application, trading, buying, selling, import, export, data processing, and internet services. It also establishes, maintains, hires, leases, and runs training centers, training schools, and campuses to provide computer training and education of computer hardware and software application, implementation, and development; runs a cyber cafe; and manages, transmits, and distributes data through own or leased telephone lines and cables. In addition, the company is involved in the software sales business; website development and designing; e-commerce solutions; and information collection, strotation, processing, and transmission services. The company was formerly known as Jindal Online.Com Limited and changed its name to Kashyap Tele-Medicines Limited in August 2005. Kashyap Tele-Medicines Limited was incorporated in 1
1. Software Sales-This segment provides Internet services and other allied services. It offers Internet services, including dial-up Internet access, dedicated lease line, ISDN Internet access, intranet, and extranet services; and Web hosting and Web designing services.
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Tata Consultancy Services (TCS) | ₹8,91,859 Cr | 18.1 | 48.43% | ₹73,188 Cr | -14.8% |
| Infosys Ltd. (Infy) | ₹4,70,326 Cr | 16 | 31.11% | ₹49,244 Cr | -21.6% |
| HCL Technologies Ltd | ₹3,73,514 Cr | 22.5 | 22.99% | ₹35,620 Cr | -6.1% |
| Wipro Ltd. | ₹1,82,433 Cr | 14.5 | 15.53% | ₹24,753 Cr | -25.2% |
| Tech Mahindra Limited | ₹1,58,567 Cr | 32.7 | 16.61% | ₹16,180 Cr | +22.3% |
| LTM Ltd | ₹1,30,203 Cr | 25.2 | 21.28% | ₹11,808 Cr | -26.5% |
| Coforge Ltd | ₹86,465 Cr | 43.8 | 18.60% | ₹6,171 Cr | +7.9% |
| Persistent Systems Ltd. | ₹85,684 Cr | 47.6 | 26.35% | ₹4,664 Cr | -2.0% |
| Kashyap Tele-Medicines Ltd | ₹31 Cr | -66.1 | -112.20% | ₹0 Cr | -12.5% |
Listed by market capitalisation. Ratios are shown for context only.
Kashyap Tele-Medicines Ltd is trading at ₹6.41, with a market capitalisation of ₹31 Cr.
Kashyap Tele-Medicines Ltd operates in the Information Technology > Software and Services > IT Services space (IT Consulting and Other Services > Information Technology (IT) Consulting).
Kashyap Tele-Medicines Ltd has a P/E of -66.1 and a return on equity of -112.20%.
Kashyap Tele-Medicines Ltd is listed on the BSE under the scrip code 531960.
Kashyap Tele-Medicines Ltd's share price is down 12.5% over one year and up 10.1% over three months. Its 52-week range is ₹4.20 to ₹12.50.
In Q1 FY27, Kashyap Tele-Medicines Ltd reported revenue of ₹0 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.03 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.